Hoth Therapeutics (HOTH)
NASDAQ:HOTH
Total Valuation
Hoth Therapeutics has a market cap or net worth of $9.14M. The enterprise value is $1.21M.
Market Cap$9.14M
Enterprise Value$1.21M
Share Statistics
Hoth Therapeutics has 16,257,652 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,257,652
Owned by Insiders3.53%
Owned by Institutions1.78%
Financial Efficiency
Hoth Therapeutics’s return on equity (ROE) is -2.03 and return on invested capital (ROIC) is -180.48%.
Return on Equity (ROE)-2.03
Return on Assets (ROA)-1.64
Return on Invested Capital (ROIC)-180.48%
Return on Capital Employed (ROCE)-1.81
Revenue Per Employee0.00
Profits Per Employee-6.23M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Hoth Therapeutics is ―. Hoth Therapeutics’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.00
PB Ratio2.22
Price to Fair Value2.22
Price to FCF-1.39
Price to Operating Cash Flow-0.89
PEG Ratio0.04
Income Statement
In the last 12 months, Hoth Therapeutics had revenue of 0.00 and earned -12.47M in profits. Earnings per share was -0.90.
Revenue0.00
Gross Profit0.00
Operating Income-11.11M
Pretax Income-12.47M
Net Income-12.47M
EBITDA-11.11M
Earnings Per Share (EPS)-0.90
Cash Flow
In the last 12 months, operating cash flow was -9.80M and capital expenditures 5.00, giving a free cash flow of -9.80M billion.
Operating Cash Flow-9.80M
Free Cash Flow-9.80M
Free Cash Flow per Share-0.60
Dividends & Yields
Hoth Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.59
52-Week Price Change-29.75%
50-Day Moving Average0.92
200-Day Moving Average1.21
Relative Strength Index (RSI)27.02
Average Volume (3m)501.79K
Important Dates
Hoth Therapeutics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Hoth Therapeutics as a current ratio of 4.72, with Debt / Equity ratio of 0.09%
Current Ratio4.72
Quick Ratio4.72
Debt to Market Cap<0.01
Net Debt to EBITDA0.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Hoth Therapeutics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Hoth Therapeutics EV to EBITDA ratio is -0.67, with an EV/FCF ratio of -0.76.
EV to Sales0.00
EV to EBITDA-0.67
EV to Free Cash Flow-0.76
EV to Operating Cash Flow-0.76
Balance Sheet
Hoth Therapeutics has $6.25M in cash and marketable securities with $5.68K in debt, giving a net cash position of $6.24M billion.
Cash & Marketable Securities$6.25M
Total Debt$5.68K
Net Cash$6.24M
Net Cash Per Share$0.38
Tangible Book Value Per Share$0.45
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Hoth Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―